TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, cilt.17, sa.4, ss.102-107, 2013 (ESCI)
Purpose: Osteoprotegerin (OPG) is a soluble decoy receptor for the receptor activator of nuclear factor kappaB ligand, thereby inhibiting bone resorption. In this study, we aimed to evaluate plasma OPG levels in patients with thyroid dysfunctions and determine whether its levels change after restoration of euthyroidism.